HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anil K Sood Selected Research

1,2-oleoylphosphatidylcholine (DOPC)

1/2019Activating p53 family member TAp63: A novel therapeutic strategy for targeting p53-altered tumors.
1/2018FABP4 as a key determinant of metastatic potential of ovarian cancer.
1/2017miR-200c-driven Mesenchymal-To-Epithelial Transition is a Therapeutic Target in Uterine Carcinosarcomas.
12/2015Long Noncoding RNA Ceruloplasmin Promotes Cancer Growth by Altering Glycolysis.
10/2015Targeting c-MYC in Platinum-Resistant Ovarian Cancer.
2/2015Adrenergic regulation of monocyte chemotactic protein 1 leads to enhanced macrophage recruitment and ovarian carcinoma growth.
5/2014EDD enhances cell survival and cisplatin resistance and is a therapeutic target for epithelial ovarian cancer.
4/2013Biological significance of HORMA domain containing protein 1 (HORMAD1) in epithelial ovarian carcinoma.
11/2011Silencing of p130cas in ovarian carcinoma: a novel mechanism for tumor cell death.
6/2011Silencing survivin splice variant 2B leads to antitumor activity in taxane--resistant ovarian cancer.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Anil K Sood Research Topics

Disease

416Neoplasms (Cancer)
06/2022 - 08/2002
256Ovarian Neoplasms (Ovarian Cancer)
04/2022 - 07/2002
81Carcinoma (Carcinomatosis)
03/2022 - 08/2002
64Neoplasm Metastasis (Metastasis)
01/2021 - 07/2005
54Ovarian Epithelial Carcinoma
11/2021 - 10/2002
21Endometrial Neoplasms (Endometrial Cancer)
12/2021 - 01/2002
19Breast Neoplasms (Breast Cancer)
12/2019 - 09/2002
15Carcinogenesis
02/2021 - 08/2004
13Hypoxia (Hypoxemia)
01/2020 - 01/2008
12Ascites
01/2021 - 09/2002
11Inflammation (Inflammations)
01/2021 - 06/2007
10Disease Progression
01/2021 - 09/2010
9Uterine Neoplasms (Uterine Cancer)
10/2021 - 04/2014
6Uterine Cervical Neoplasms (Cancer of the Cervix)
09/2022 - 04/2002
6Triple Negative Breast Neoplasms
12/2019 - 10/2012
6Colorectal Neoplasms (Colorectal Cancer)
01/2019 - 01/2008
6Fatigue
01/2018 - 09/2010
5Hypertension (High Blood Pressure)
02/2018 - 07/2011
5Pancreatic Neoplasms (Pancreatic Cancer)
10/2009 - 09/2002
4Lung Neoplasms (Lung Cancer)
01/2019 - 03/2014
4Colonic Neoplasms (Colon Cancer)
08/2017 - 07/2005
4Melanoma (Melanoma, Malignant)
01/2016 - 11/2008
4Prostatic Neoplasms (Prostate Cancer)
10/2015 - 12/2010
4Adenocarcinoma
11/2014 - 01/2002

Drug/Important Bio-Agent (IBA)

71Small Interfering RNA (siRNA)IBA
01/2021 - 08/2005
55Proteins (Proteins, Gene)FDA Link
03/2022 - 09/2006
45Biological ProductsIBA
04/2022 - 10/2004
44Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2022 - 08/2002
41MicroRNAs (MicroRNA)IBA
02/2020 - 06/2011
36Biomarkers (Surrogate Marker)IBA
03/2022 - 10/2006
36Paclitaxel (Taxol)FDA LinkGeneric
10/2021 - 02/2004
35PlatinumIBA
01/2021 - 08/2003
27Docetaxel (Taxotere)FDA Link
01/2018 - 02/2004
26Adrenergic Agents (Adrenergic Drugs)IBA
07/2020 - 08/2006
25Cisplatin (Platino)FDA LinkGeneric
01/2022 - 04/2002
24Pharmaceutical PreparationsIBA
12/2021 - 12/2007
211,2-oleoylphosphatidylcholine (DOPC)IBA
01/2019 - 08/2005
19CytokinesIBA
04/2022 - 08/2002
19Interleukin-6 (Interleukin 6)IBA
09/2021 - 07/2005
18Messenger RNA (mRNA)IBA
11/2021 - 11/2003
17Norepinephrine (Noradrenaline)FDA LinkGeneric
01/2021 - 01/2006
16Hormones (Hormone)IBA
09/2022 - 01/2006
16Bevacizumab (Avastin)FDA Link
04/2022 - 12/2007
16DNA (Deoxyribonucleic Acid)IBA
03/2022 - 09/2006
16taxaneIBA
11/2017 - 12/2005
14Phosphotransferases (Kinase)IBA
01/2020 - 08/2004
14Focal Adhesion Protein-Tyrosine KinasesIBA
05/2019 - 10/2004
12RNA (Ribonucleic Acid)IBA
04/2022 - 11/2013
11Hydrocortisone (Cortisol)FDA LinkGeneric
01/2021 - 01/2006
11Matrix Metalloproteinases (MMPs)IBA
01/2021 - 04/2004
11Liposomes (Liposome)IBA
05/2019 - 08/2005
10LigandsIBA
01/2020 - 02/2007
10CatecholaminesIBA
10/2018 - 08/2006
9Poly(ADP-ribose) Polymerase InhibitorsIBA
12/2021 - 07/2015
9Interleukin-8 (Interleukin 8)IBA
01/2021 - 03/2008
9ChitosanIBA
01/2020 - 08/2010
8Carboplatin (JM8)FDA LinkGeneric
10/2021 - 02/2004
8EnzymesIBA
01/2021 - 02/2006
8Monoclonal AntibodiesIBA
01/2020 - 10/2006
8Adrenergic Receptors (Adrenergic Receptor)IBA
01/2020 - 08/2006
7Topotecan (Hycamtin)FDA LinkGeneric
01/2022 - 09/2004
7olaparibIBA
12/2021 - 07/2015
7Long Noncoding RNAIBA
02/2021 - 10/2013
7Estrogen ReceptorsIBA
12/2019 - 05/2009
7Doxorubicin (Adriamycin)FDA LinkGeneric
01/2019 - 01/2012
7Transcription Factors (Transcription Factor)IBA
10/2018 - 06/2007
7LipidsIBA
01/2018 - 02/2014
7Epinephrine (Adrenaline)FDA LinkGeneric
02/2016 - 01/2006
7afliberceptIBA
01/2016 - 10/2005
7Proliferating Cell Nuclear Antigen (PCNA)IBA
11/2011 - 09/2006
6Progesterone Receptors (Progesterone Receptor)IBA
12/2020 - 05/2009
6Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2020 - 08/2004
6Indicators and Reagents (Reagents)IBA
01/2015 - 03/2009
6Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA
05/2013 - 08/2006
5CollagenIBA
03/2022 - 04/2004
5Dasatinib (BMS 354825)FDA Link
10/2021 - 08/2011
5Taxoids (Taxanes)IBA
01/2020 - 11/2006
5Propranolol (Inderal)FDA LinkGeneric
01/2019 - 01/2006
5ErbB Receptors (EGF Receptor)IBA
11/2017 - 07/2005
5Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
06/2016 - 07/2005
4Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2021 - 12/2010
4Peptides (Polypeptides)IBA
11/2020 - 04/2014
4AntigensIBA
02/2020 - 07/2014
4RNA-Binding Proteins (RNA-Binding Protein)IBA
01/2019 - 09/2014
4Therapeutic UsesIBA
01/2019 - 04/2011
4Aurora KinasesIBA
01/2018 - 09/2008
4Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2018 - 07/2016
4Angiogenesis InhibitorsIBA
12/2017 - 05/2010
4Tyrosine Kinase InhibitorsIBA
11/2017 - 07/2005
4Histones (Histone)IBA
10/2013 - 09/2008

Therapy/Procedure

179Therapeutics
09/2022 - 01/2002
81Drug Therapy (Chemotherapy)
09/2022 - 07/2004
15Neoadjuvant Therapy
03/2022 - 07/2009
10Cytoreduction Surgical Procedures
01/2021 - 07/2004
8Radiotherapy
09/2022 - 02/2010
8Immunotherapy
01/2021 - 07/2014
8Hysterectomy
01/2017 - 10/2002
7Lasers (Laser)
07/2021 - 01/2011
6Lymph Node Excision (Lymph Node Dissection)
09/2017 - 04/2009
4Aftercare (After-Treatment)
09/2022 - 12/2005